Lowering apolipoprotein CIII delays onset of type 1 diabetes

Serum levels of apolipoprotein CIII (apoCIII) are increased in type 1 diabetic patients, and when β cells are exposed to these diabetic sera, apoptosis occurs, an effect abolished by an antibody against apoCIII. We have investigated the BB rat, an animal model that develops a human-like type 1 diabe...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Holmberg, Rebecka, Refai, Essam, Höög, Anders, Crooke, Rosanne M., Graham, Mark, Olivecrona, Gunilla, Berggren, Per-Olof, Juntti-Berggren, Lisa
Format: Artigo
Jezik:Inglês
Izdano: National Academy of Sciences 2011
Teme:
Biological Sciences
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3127896/
https://ncbi.nlm.nih.gov/pubmed/21670290
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.1019553108
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items